Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion

Use of yttrium-90 (Y-90) is used for primary liver tumors and a handful of liver metastatic lesions. Y-90 treatment for metastatic adrenocortical carcinoma (ACC) to the liver is currently off-label, with one previously documented case report. In this case report, we present a 52-year-old woman with...

Full description

Bibliographic Details

Published in:	Case Reports in Oncology
Main Authors:	Nicholas Pigg, Daniel Aboubechara, Roberto Fourzali, Brian Baigorri
Format:	Article
Language:	English
Published:	Karger Publishers 2020-02-01
Subjects:	yttrium-90 radioembolization adrenocortical carcinoma hepatic metastases
Online Access:	https://www.karger.com/Article/FullText/504779